-
Inhibition of SKP2 Sensitizes Bromocriptine-Induced Apoptosis in Human Prolactinoma Cells
-
Jinxiang Huang, Fenglin Zhang, Lei Jiang, Guohan Hu, Wei Sun, Chenran Zhang, Xuehua Ding
-
Cancer Res Treat. 2017;49(2):358-373. Published online July 28, 2016
-
DOI: https://doi.org/10.4143/crt.2016.017
-
-
 Abstract
 PDF Supplementary Material PubReader ePub
- Purpose
Prolactinoma (prolactin-secreting pituitary adenoma) is one of the most common estrogen-related functional pituitary tumors. As an agonist of the dopamine D2 receptor, bromocriptine is used widely to inhibit prolactinoma progression. On the other hand, it is not always effective in clinical application. Although a dopamine D2 receptor deficiency contributes to the impaired efficiency of bromocriptine therapy to some extent, it is unknown whether there some other underlying mechanisms leading to bromocriptine resistance in prolactinoma treatment. That is the main point addressed in this project.
Materials and Methods
Human prolactinoma samples were used to analyze the S-phase kinase associated protein 2 (SKP2) expression level. Nutlin-3/adriamycin/cisplatin-treated GH3 and MMQ cells were used to analyze apoptosis in SKP2 overexpression or knockdown cells. SKP2 expression and the interaction partners of SKP2 were also detected after a bromocriptine treatment in 293T. Apoptosis was analyzed in C25 and bromocriptine-treated GH3 cells.
Results
Compared to normal pituitary samples, most prolactinoma samples exhibit higher levels of SKP2 expression, which could inhibit apoptosis in a p53-dependent manner. In addition, the bromocriptine treatment prolonged the half-life of SKP2 and resulted in SKP2 overexpression to a greater extent, which in turn compromised its pro-apoptotic effect. As a result, the bromocriptine treatment combined with C25 (a SKP2 inhibitor) led to the maximal apoptosis of human prolactinoma cells.
Conclusion
These findings indicated that SKP2 inhibition sensitized the prolactinoma cells to bromocriptine and helped promote apoptosis. Moreover, a combined treatment of bromocriptine and C25 may contribute to the maximal apoptosis of human prolactinoma cells.
-
Citations
Citations to this article as recorded by  - SKping cell cycle regulation: role of ubiquitin ligase SKP2 in hematological malignancies
Jonahunnatha Nesson George William, Ruby Dhar, Rohit Gundamaraju, Om Saswat Sahoo, Karthikeyan Pethusamy, A. F. P. Allwin Mabes Raj, Subbiah Ramasamy, Mohammed S. Alqahtani, Mohamed Abbas, Subhradip Karmakar
Frontiers in Oncology.2024;[Epub] CrossRef - Bortezomib exerts its anti-cancer activity through the regulation of Skp2/p53 axis in non-melanoma skin cancer cells and C. elegans
Kirti S. Prabhu, Fareed Ahmad, Shilpa Kuttikrishnan, Rari Leo, Tayyiba Akbar Ali, Mahmoud Izadi, Jericha M. Mateo, Majid Alam, Aamir Ahmad, Ammira S. Al-Shabeeb Akil, Ajaz A. Bhat, Joerg Buddenkotte, Ehsan Pourkarimi, Martin Steinhoff, Shahab Uddin
Cell Death Discovery.2024;[Epub] CrossRef - Prenatal p25-activated Cdk5 induces pituitary tumorigenesis through MCM2 phosphorylation-mediated cell proliferation
Yingwei Huang, Qiqi Wang, Weiwei Zhou, Yawei Jiang, Kai He, Wei Huang, Yating Feng, Hong Wu, Lijuan Liu, Yue Pan, Yihua Huang, Zirui Chen, Wei Li, Yaowei Huang, Guanchuan Lin, Yulong Zhang, Yongyan Ren, Kaibiao Xu, Yanlin Yu, Yuping Peng, Xinghua Pan, Suy
Neoplasia.2024; 57: 101054. CrossRef - N-Myc transcriptionally activates Skp2 to suppress p27 expression in small cell lung cancer
Juntao Zou, Yang Lin, Min Hu, Mengzhi Wan, Xinyu Tan, Xinping Xu, Fei Xu
Pathology - Research and Practice.2022; 238: 154083. CrossRef - Targeting the Hippo Pathway in Prostate Cancer: What’s New?
Kelly Coffey
Cancers.2021; 13(4): 611. CrossRef - Emerging Roles of SKP2 in Cancer Drug Resistance
Ting Wu, Xinsheng Gu, Hongmei Cui
Cells.2021; 10(5): 1147. CrossRef - ZNF703 is Overexpressed in Papillary Thyroid Carcinoma Tissues and Mediates K1 Cell Proliferation
Xiaolin Yang, Geling Liu, Luyang Zang, Ding Li, Fang Yu, Xiuxiu Xiang, Weijuan Li
Pathology & Oncology Research.2020; 26(1): 355. CrossRef - Skp2 in the ubiquitin‐proteasome system: A comprehensive review
Moges Dessale Asmamaw, Ying Liu, Yi‐Chao Zheng, Xiao‐Jing Shi, Hong‐Min Liu
Medicinal Research Reviews.2020; 40(5): 1920. CrossRef - Genomic and molecular characterization of pituitary adenoma pathogenesis: review and translational opportunities
Mazin Elsarrag, Parantap D. Patel, Ajay Chatrath, Davis Taylor, John A. Jane
Neurosurgical Focus.2020; 48(6): E11. CrossRef - PGAM5-CypD pathway is involved in bromocriptine-induced RIP3/MLKL-dependent necroptosis of prolactinoma cells
Shun-Li Zhang, Hai-Bin Tang, Jin-Tao Hu, Zhen-Le Zang, Xiao Ding, Song Li, Hui Yang
Biomedicine & Pharmacotherapy.2019; 111: 638. CrossRef - Role and mechanisms of a three-dimensional bioprinted microtissue model in promoting proliferation and invasion of growth-hormone-secreting pituitary adenoma cells
Jinfu Diao, Chuanbao Zhang, Dainan Zhang, Xiong Wang, Jing Zhang, Cheng Ma, Kunxue Deng, Tao Jiang, Wang Jia, Tao Xu
Biofabrication.2019; 11(2): 025006. CrossRef - Skp2 inhibitor SKPin C1 decreased viability and proliferation of multiple myeloma cells and induced apoptosis
Ying Yang, Wei Yan, Zhuogang Liu, Minjie Wei
Brazilian Journal of Medical and Biological Research.2019;[Epub] CrossRef - Dysregulated expression of SKP2 and its role in hematological malignancies
Michal Kulinski, Iman W. Achkar, Mohammad Haris, Said Dermime, Ramzi M. Mohammad, Shahab Uddin
Leukemia & Lymphoma.2018; 59(5): 1051. CrossRef - The prolactin‐release inhibitor paeoniflorin suppresses proliferation and induces apoptosis in prolactinoma cells via the mitochondria‐dependent pathway
Yuanyi Wei, Xia Zhou, Liying Ren, Chunxia Wang, Yuhao Li
Journal of Cellular Biochemistry.2018; 119(7): 5704. CrossRef - Relation among Aromatase P450 and Tumoral Growth in Human Prolactinomas
María García-Barrado, Enrique Blanco, María Iglesias-Osma, Marta Carretero-Hernández, Leonardo Catalano-Iniesta, Virginia Sanchez-Robledo, Manuel Carretero, Julio Herrero, Sixto Carrero, José Carretero
International Journal of Molecular Sciences.2017; 18(11): 2299. CrossRef
-
17,937
View
-
240
Download
-
16
Web of Science
-
15
Crossref
|
KCA
